|
|
|
|
|
|
|
|
|
|
|
07.10.26 - 10:57
|
Spotify Aktie: AI Remix vor dem Start - UBS bleibt bei "buy" und sieht 675 USD (Aktiencheck)
|
|
|
Zürich (www.aktiencheck.de) - Spotify-Aktienanalyse von der UBS:
Die Analysten der UBS stufen die Aktie der Spotify Technology S.A. (ISIN: LU1778762911, WKN: A2JEGN, Ticker-Symbol: 639, NYSE-Symbol: SPOT) weiterhin mit "buy" ein und senken das Kursziel von 690 auf 675 USD.
Spotify sei weiterhin gut positioniert, um Fortschritte bei seinen Finanzzielen zu erzielen, wobei differenzierte Produkteinführungen und neue Monetarisierungsmöglichkeiten trotz höherer Kosten für Investitionen in die Plattform die operative Hebelwirkung unterstützen würden. [mehr]...
|
|
|
|
|
|
|
|
|
|
|
|
|
05.10.26 - 18:03
|
Function Accelerates Growth with Strategic Hire, Taj Alavi, Former Marketing Leader at Spotify, Uber, and Instagram, to Serve as Chief Marketing Officer (PR Newswire)
|
|
|
Alavi has helped define how the world shares, moves, and listens. Now she joins Function to change how people own their health. AUSTIN, Texas, Oct. 5, 2026 /PRNewswire/ -- Today, Function announced that Taj Alavi has joined as its first Chief Marketing Officer. Alavi will lead Function's......
|
|
|
|
|
|
|
|
|
|
|
|
|
30.09.26 - 22:21
|
Is Neko Health′s body scan worth it? Spotify billionaire′s startup has come to America (TechCrunch)
|
|
|
Spotify founder Daniel Ek's Neko Health raised $700 million to build a business around scanning your body, but it's not the only company centering its roadmap around a new kind of preventative healthcare. Midjourney is building its own body scanner, while Function Health has also raised significant capital to build out its preventative-health platform. Why are are investors betting so big on this category? On this episode of TechCrunch's Equity podcast, […]...
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
